Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe
Glenmark Pharmaceuticals Ltd 路 Intimation 路 10 Nov 2026, 12:41 am
Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe Glenmark Pharmaceuticals has scheduled physical analyst and institutional investor meetings across international locations. The company will conduct both group and one-on-one sessions in Taiwan and Singapore from 16th Nov'26 to 18th Nov'26. Additionally, a group investor meeting is slated for 23rd Nov'26 in Switzerland. The company confirmed that no unpublished price-sensitive information will be shared during these interactions.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Initmation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
- Investor Presentation for the quarter and half year ended September 30, 2026 路 05 Nov 2026
